Form 8-K INTERNATIONAL FLAVORS & For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
International Flavors & Fragrances (IFF) PT Raised to $85 at BofA Securities
March 20, 2024 2:10 PM EDTBofA Securities analyst Matthew DeYoe raised the price target on International Flavors & Fragrances (NYSE: IFF) to $85.00 (from $83.00) while maintaining a Neutral rating.
The analyst comments "Yesterday, IFF announced an agreement to sell its Pharma Solutions business to Roquette for $2.85bn. The transaction reflects a... More
International Flavors & Fragrances (IFF) PT Raised to $100 at Deutsche Bank
March 20, 2024 5:19 AM EDTDeutsche Bank analyst David Begleiter raised the price target on International Flavors & Fragrances (NYSE: IFF) to $100.00 (from $90.00) while maintaining a Buy rating.
The analyst comments "With the sale of Pharma Solutions, IFF has taken a major step in reducing its leverage below 3x and thus removing the leverage overhang on the shares that has existed since the... More
International Flavors & Fragrances (IFF) PT Raised to $85 at Stifel
March 19, 2024 10:24 AM EDTStifel analyst Mark Astachan raised the price target on International Flavors & Fragrances (NYSE: IFF) to $85.00 (from $80.00) while maintaining a Hold rating after selling its Pharma business for up to $2.85 billion.
The analyst commented, "IFF announced the sale of its Pharma business for up to $2.85bn,... More

